Susheel Jethanand Nara

Person

Karnataka, IN

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,059,420
- Issue date Aug 13, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted amide compounds useful as farnesoid X receptor modulators
- Patent number 12,030,835
- Issue date Jul 9, 2024
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,713,312
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,337,970
- Issue date May 24, 2022
- Bristol-Myers Squibb Company
- Emily Charlotte Cherney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,254,663
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,253,525
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,959,986
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged bicyclic compounds as farnesoid X receptor modulators
- Patent number 10,730,863
- Issue date Aug 4, 2020
- Bristol-Myers Squibb Company
- David S. Yoon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biaryl kinase inhibitors
- Patent number 10,544,120
- Issue date Jan 28, 2020
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,932
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,933
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl lactam kinase inhibitors
- Patent number 10,253,027
- Issue date Apr 9, 2019
- Bristol-Myers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biaryl kinase inhibitors
- Patent number 10,246,469
- Issue date Apr 2, 2019
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridines as kinase inhibitors
- Patent number 10,174,044
- Issue date Jan 8, 2019
- Bristol-Myers Squibb Company
- Susheel Jethanand Nara
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IDO inhibitors
- Patent number 10,167,254
- Issue date Jan 1, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic kinase inhibitors
- Patent number 10,035,777
- Issue date Jul 31, 2018
- Bristol-Myers Squibb Company
- Carolyn Diane Dzierba
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline-based kinase inhibitors
- Patent number 9,932,320
- Issue date Apr 3, 2018
- Bristol-Myers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IDO inhibitors
- Patent number 9,790,169
- Issue date Oct 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl amide-based kinase inhibitors
- Patent number 9,708,337
- Issue date Jul 18, 2017
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl ether-base kinase inhibitors
- Patent number 8,969,564
- Issue date Mar 3, 2015
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl lactam kinase inhibitors
- Patent number 8,901,305
- Issue date Dec 2, 2014
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl ether-base kinase inhibitors
- Patent number 8,703,953
- Issue date Apr 22, 2014
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SMALL MOLECULE INHIBITORS OF GALECTIN-3
- Publication number 20230212158
- Publication date Jul 6, 2023
- Bristol-Myers Squibb Company
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SMALL MOLECULE INHIBITORS OF GALECTIN-3
- Publication number 20230192672
- Publication date Jun 22, 2023
- Bristol-Myers Squibb
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20230109670
- Publication date Apr 6, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220213026
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220162201
- Publication date May 26, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SMALL MOLECULE INHIBITORS OF GALECTIN-3
- Publication number 20220144818
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220135550
- Publication date May 5, 2022
- Bristol-Myers Squibb Company
- Dean A. WACKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220081430
- Publication date Mar 17, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210355113
- Publication date Nov 18, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210299126
- Publication date Sep 30, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210290613
- Publication date Sep 23, 2021
- Bristol-Myers Squibb Company
- Emily Charlotte CHERNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20210261535
- Publication date Aug 26, 2021
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069646
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069695
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20190127358
- Publication date May 2, 2019
- Bristol-Myers Squibb Company
- David S. Yoon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIARYL KINASE INHIBITORS
- Publication number 20190040080
- Publication date Feb 7, 2019
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIARYL KINASE INHIBITORS
- Publication number 20180346440
- Publication date Dec 6, 2018
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRIDINES AS KINASE INHIBITORS
- Publication number 20180141956
- Publication date May 24, 2018
- Bristol-Myers Squibb Company
- Susheel Jethanand Nara
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180079712
- Publication date Mar 22, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180072660
- Publication date Mar 15, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC KINASE INHIBITORS
- Publication number 20170260145
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Carolyn Diane Dzierba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINE-BASED KINASE INHIBITORS
- Publication number 20170239249
- Publication date Aug 24, 2017
- Bristol-Myers Squibb Company
- Richard A. HARTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDO INHIBITORS
- Publication number 20170231999
- Publication date Aug 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL LACTA KINASE INHIBITORS
- Publication number 20160333006
- Publication date Nov 17, 2016
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline-Based Kinase Inhibitors
- Publication number 20160332985
- Publication date Nov 17, 2016
- Bristol-Meyers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDO INHIBITORS
- Publication number 20160289171
- Publication date Oct 6, 2016
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL ETHER-BASE KINASE INHIBITORS
- Publication number 20160222021
- Publication date Aug 4, 2016
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL LACTAM KINASE INHIBITORS
- Publication number 20160152621
- Publication date Jun 2, 2016
- Bristol-Myers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AMIDE-BASED KINASE INHIBITORS
- Publication number 20160016967
- Publication date Jan 21, 2016
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl Ether-Base Kinase Inhibitors
- Publication number 20140179725
- Publication date Jun 26, 2014
- Vivekananda M. Vrudhula
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Susheel Jethanand Nara

Person

Patents Grantslast 30 patents

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Substituted amide compounds useful as farnesoid X receptor modulators

Substituted bicyclic compounds as farnesoid X receptor modulators

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Substituted bicyclic compounds as farnesoid X receptor modulators

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Bridged bicyclic compounds as farnesoid X receptor modulators

Biaryl kinase inhibitors

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Aryl lactam kinase inhibitors

Biaryl kinase inhibitors

Fused pyridines as kinase inhibitors

IDO inhibitors

Heterocyclic kinase inhibitors

Quinoline-based kinase inhibitors

IDO inhibitors

Aryl amide-based kinase inhibitors

Aryl ether-base kinase inhibitors

Aryl lactam kinase inhibitors

Aryl ether-base kinase inhibitors

Patents Applicationslast 30 patents

SMALL MOLECULE INHIBITORS OF GALECTIN-3

SMALL MOLECULE INHIBITORS OF GALECTIN-3

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SMALL MOLECULE INHIBITORS OF GALECTIN-3

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

BIARYL KINASE INHIBITORS

BIARYL KINASE INHIBITORS

FUSED PYRIDINES AS KINASE INHIBITORS

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

HETEROCYCLIC KINASE INHIBITORS

QUINAZOLINE-BASED KINASE INHIBITORS

IDO INHIBITORS

ARYL LACTA KINASE INHIBITORS

Quinoline-Based Kinase Inhibitors

IDO INHIBITORS

ARYL ETHER-BASE KINASE INHIBITORS

ARYL LACTAM KINASE INHIBITORS

ARYL AMIDE-BASED KINASE INHIBITORS

Aryl Ether-Base Kinase Inhibitors